氟康唑治疗恶性血液病化疗后真菌感染21例
摘要
目的观察氟康唑治疗恶性血液病化疗后合并真菌感染的疗效。方法对1998年7月至2006年6月收治的21例恶性血液病化疗后合并真菌感染的患者作回顾性分析。结果总有效率为76．19％（16／21），确诊病例为71．43％（5／7），临床诊断病例为90．91％（10／11），拟诊病例66．66％（2／3）。结论氟康唑对恶性血液病化疗后合并真菌感染的患者疗效确切，价格较低，可作为一线治疗推荐药物。
出处
《白血病．淋巴瘤》
CAS
2008年第3期212-213,共2页
Journal of Leukemia & Lymphoma
参考文献3
-
1Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J]. Clin Infect Dis, 2002, 34(1): 7-14.
-
2荣蓉,吴斌.深部真菌感染药物治疗进展[J].内科,2006,1(1):45-47. 被引量：4
-
3Lyman CA, Garrett KF, Peter J, et al. Increased adherence of fluconazole-resistant isolates of candida species to explanted esophageal mucosa[J]. Eur Clin Microbiol Infect Dis, 1999, 18(3): 213-216.
二级参考文献12
-
1金有豫.抗真菌药[J].首都医药,2004,11(12):7-10. 被引量：3
-
2Martin R. Carby,Margaret E. Hodson,Nicholas R. Banner. Refractory pulmonary aspergillosis treated with caspofungin after heart–lung transplantation[J] 2004,Transplant International(9):545～548
-
3U. Frank,M. Greiner,I. Engels,F. D. Daschner. Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes[J] 2004,European Journal of Clinical Microbiology & Infectious Diseases(9):729～731
-
4M. Drago,M. M. Scaltrito,G. Morace. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei[J] 2004,European Journal of Clinical Microbiology & Infectious Diseases(8):619～624
-
5T. Yokote,T. Akioka,S. Oka,T. Fujisaka,T. Yamano,S. Hara,M. Tsuji,T. Hanafusa. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy[J] 2004,Annals of Hematology(1):64～66
-
6C. Lass-Fl?rl,E. Gunsilius,G. Gastl,M. Englisch,G. Koch,H. Ulmer,M. P. Dierich,A. Petzer. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution[J] 2003,Annals of Hematology(9):565～569
-
7M. Cuenca-Estrella,T. M. Díaz-Guerra,E. Mellado,A. Monzón,J. L. Rodríguez-Tudela. Comparative in Vitro Activity of Voriconazole and Itraconazole Against Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida Species from Spain[J] 1999,European Journal of Clinical Microbiology and Infectious Diseases(6):432～435
-
8C. A. Lyman,K. F. Garrett,J. Peter,C. Gonzalez,T. J. Walsh. Increased Adherence of Fluconazole-Resistant Isolates of Candida Species to Explanted Esophageal Mucosa[J] 1999,European Journal of Clinical Microbiology and Infectious Diseases(3):213～216
-
9Andras Vermes,Heleen van der Sijs,Henk‐jan Guchelaar. An accelerated stability study of 5‐flucytosine in intravenous solution[J] 1999,Pharmacy World Science(1):35～39
-
10G. Angarano,P. Maggi,S. L. Coppola,R. L. Cavaliere. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients[J] 1998,European Journal of Clinical Microbiology & Infectious Diseases(5):365～367
共引文献3
-
1朱曼,郭代红,刘皈阳.从一例重症感染患者的药学监护探讨临床药学服务的切入点[J].中国药物应用与监测,2009,6(2):108-110. 被引量：7
-
2郑力强.维和任务区常见真菌病的合理用药[J].华北国防医药,2010,22(6):593-594. 被引量：1
-
3胡学琼,张学军,李一辉.氟康唑治疗恶性肿瘤化疗后并发真菌感染26例分析[J].中国药物与临床,2011,11(4):453-454.
-
1续哲莉,任辉.谈谈直肠癌的治疗[J].抗癌,2004(3):12-12.
-
2续哲莉,任辉,王巍.直肠癌的治疗进展[J].实用肿瘤学杂志,2004,18(2):152-154.
-
3熊慧华,余忠贞,石磊,杨林,陈元.伊曲康唑对比氟康唑治疗老年恶性肿瘤合并深部真菌感染的研究[J].中国血液流变学杂志,2009,19(1):75-77.
-
4李永辉,曾晓颖,姚宇红,王爱华,沈志祥.氟康唑治疗血液系统疾病伴发真菌感染[J].白血病．淋巴瘤,2003,12(5):300-301.
-
5刘兴元,谢晓恬,杨剑倩.儿童急性白血病深部真菌感染的研究[J].铁道医学,1998,26(4):230-232. 被引量：1
-
6宋瑞英,陈尧,王贵华.50例恶性胸水的临床与病理分析[J].临床内科杂志,1995,12(5):26-27.
-
7李金龙.2%碘酊联合氟康唑治疗真菌性角膜溃疡的临床观察[J].基层医学论坛,2009,13(20):592-593.
-
8王红忠,刘唯,程由勇,李红玖,姚志文,杨安,刘荫.氟康唑治疗老年口腔念珠菌40例临床观察[J].中国医药科学,2013,3(11):80-81. 被引量：4
-
9杨发满,郭杰,贾乃镛,李湛全.氟康唑治疗血液系统恶性疾病继发真菌感染临床观察[J].青海医药杂志,1995,25(6):38-38.
-
10苏忠学,常宏,吴泰璜.胰腺实性假乳头状肿瘤[J].山东医药,2008,48(35):104-104. 被引量：2
